Veterinary Pain Medication - Global and China Top Players Market Share and Ranking 2023
According to Latest Study , the global market for Veterinary Pain Medication should grow from US$ 4636 million in 2023 to US$ 7124.4 million by 2030, with a CAGR of 6.3% for the period of 2024-2030.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Veterinary Pain Medication market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Veterinary Pain Medication market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Veterinary Hospitals grew percent to account for percent of the total market sales, and Veterinary Clinics grew percent.
This report studies and analyses global Veterinary Pain Medication status and future trends, helps the client to determine the Veterinary Pain Medication market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Veterinary Pain Medication, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2023 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Veterinary Pain Medication market size, history data 2019-2024, and forecast data 2024 -2030, (US$ million) & (K Units)
(2) Global Veterinary Pain Medication sales, revenue, price by company, market share and industry ranking 2019-2024, (US$ million) & (K Units)
(3) China Veterinary Pain Medication sales, revenue, price by company, market share and industry ranking 2019-2024, (US$ million) & (K Units)
(4) Global Veterinary Pain Medication key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Veterinary Pain Medication key producing regions, capacity, production, and year over year growth
(6) Veterinary Pain Medication industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Boehringer Ingelheim
Elanco
Zoetis
Baxter
Halyard
Endo International
Forest Laboratories
Medtronic
Bayer Pharma AG
Ceva Sante Animale
Ringpu Bio-technology
Ruicheng Lvman Biological Pharmaceutical Co., Ltd.
Norbrook Laboratories
Merck & Co
Bostonscientific
Lilly
Pfizer
Harbin Bolai Pharmaceutical Co., Ltd.
Market segment by Type, covers
Injection Medicines
Oral Medicines
Market segment by Application, can be divided into
Veterinary Hospitals
Veterinary Clinics
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Veterinary Pain Medication product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Veterinary Pain Medication market share and ranking of major manufacturers, sales quantity, revenue, average price, 2019-2024
Chapter 3: China Veterinary Pain Medication market share and ranking of major manufacturers, sales quantity, revenue, average price, 2019-2024
Chapter 4: Global key producing regions of Veterinary Pain Medication, percent & CAGR, 2019-2030
Chapter 5: Veterinary Pain Medication industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Veterinary Pain Medication Definition
1.2 Global Veterinary Pain Medication Market Size and Forecast
1.2.1 By Consumption Value, Global Veterinary Pain Medication Market Size，2019-2030
1.2.2 By Sales Quantity, Global Veterinary Pain Medication Market Size，2019-2030
1.2.3 Global Veterinary Pain Medication Average Selling Price (ASP)，2019-2030
1.3 China Veterinary Pain Medication Market Size and Forecast
1.3.1 By Consumption Value, China Veterinary Pain Medication Market Size，2019-2030
1.3.2 By Sales Quantity, China Veterinary Pain Medication Market Size，2019-2030
1.3.3 China Veterinary Pain Medication Average Selling Price (ASP)， 2019-2030
1.4 Share of China Veterinary Pain Medication Market with Respect to the Global Market
1.4.1 By Consumption Value, China Veterinary Pain Medication Market Share in Global, 2019-2030
1.4.2 By Sales Quantity, China Veterinary Pain Medication Market Share in Global, 2019-2030
1.4.3 Veterinary Pain Medication Market Size: China VS Global, 2019-2030
1.5 Veterinary Pain Medication Market Dynamics
1.5.1 Veterinary Pain Medication Market Drivers
1.5.2 Veterinary Pain Medication Market Restraints
1.5.3 Veterinary Pain Medication Industry Trends
1.5.4 Veterinary Pain Medication Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Veterinary Pain Medication, Global Market Share by Company, 2019-2024
2.2 By Sales Quantity of Veterinary Pain Medication, Global Market Share by Company, 2019-2024
2.3 Veterinary Pain Medication Average Selling Price (ASP) by Company, 2019-2024
2.4 Global Veterinary Pain Medication Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Veterinary Pain Medication Concentration Ratio
2.6 Global Veterinary Pain Medication Mergers & Acquisitions, Expansion Plans
2.7 Global Veterinary Pain Medication Manufacturers Product Type
2.8 Head Office and Veterinary Pain Medication Production Site of Key Manufacturer
2.9 Veterinary Pain Medication Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Veterinary Pain Medication, China Market Share by Company, 2019-2024
3.2 By Sales Quantity of Veterinary Pain Medication, China Market Share by Company, 2019-2024
3.3 China Veterinary Pain Medication Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Veterinary Pain Medication Capacity, Output and Capacity Utilization, 2019-2030
4.2 Global Veterinary Pain Medication Capacity by Region
4.3 Global Veterinary Pain Medication Production & Forecast by Region, 2019 VS 2023 VS 2030
4.4 Global Veterinary Pain Medication Production by Region, 2019-2030
4.5 Global Veterinary Pain Medication Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Veterinary Pain Medication Industry Chain
5.2 Veterinary Pain Medication Upstream Analysis
5.2.1 Veterinary Pain Medication Core Raw Materials
5.2.2 Main Manufacturers of Veterinary Pain Medication Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Veterinary Pain Medication Production Mode
5.6 Veterinary Pain Medication Procurement Model
5.7 Veterinary Pain Medication Industry Sales Model and Sales Channels
5.7.1 Veterinary Pain Medication Sales Model
5.7.2 Veterinary Pain Medication Typical Distributors
6 Sights by Type
6.1 Veterinary Pain Medication Classification
6.1.1 Injection Medicines
6.1.2 Oral Medicines
6.2 By Type, Global Veterinary Pain Medication Consumption Value & CAGR, 2019 VS 2023 VS 2030
6.3 By Type, Global Veterinary Pain Medication Consumption Value, 2019-2030
6.4 By Type, Global Veterinary Pain Medication Sales Quantity, 2019-2030
6.5 By Type, Global Veterinary Pain Medication Average Selling Price (ASP), 2019-2030
7 Sights by Application
7.1 Veterinary Pain Medication Segment by Application
7.1.1 Veterinary Hospitals
7.1.2 Veterinary Clinics
7.1.3 Others
7.2 By Application, Global Veterinary Pain Medication Consumption Value & CAGR, 2019 VS 2023 VS 2030
7.3 By Application, Global Veterinary Pain Medication Consumption Value, 2019-2030
7.4 By Application, Global Veterinary Pain Medication Sales Quantity, 2019-2030
7.5 By Application, Global Veterinary Pain Medication Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Veterinary Pain Medication Consumption Value, 2019 VS 2023 VS 2030
8.2 By Region, Global Veterinary Pain Medication Consumption Value, 2019-2030
8.3 By Region, Global Veterinary Pain Medication Sales Quantity, 2019-2030
8.4 North America
8.4.1 North America Veterinary Pain Medication & Forecasts, 2019-2030
8.4.2 By Country, North America Veterinary Pain Medication Market Size Market Share
8.5 Europe
8.5.1 Europe Veterinary Pain Medication Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Veterinary Pain Medication Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Veterinary Pain Medication Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Veterinary Pain Medication Market Size Market Share
8.7 South America
8.7.1 South America Veterinary Pain Medication Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Veterinary Pain Medication Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Veterinary Pain Medication Market Size & CAGR, 2019 VS 2023 VS 2030
9.2 By Country, Global Veterinary Pain Medication Consumption Value, 2019-2030
9.3 By Country, Global Veterinary Pain Medication Sales Quantity, 2019-2030
9.4 U.S.
9.4.1 U.S. Veterinary Pain Medication Market Size, 2019-2030
9.4.2 By Type, U.S. Veterinary Pain Medication Sales Quantity Market Share, 2023 VS 2030
9.4.3 By Application, U.S. Veterinary Pain Medication Sales Quantity Market Share, 2023 VS 2030
9.5 Europe
9.5.1 Europe Veterinary Pain Medication Market Size, 2019-2030
9.5.2 By Type, Europe Veterinary Pain Medication Sales Quantity Market Share, 2023 VS 2030
9.5.3 By Application, Europe Veterinary Pain Medication Sales Quantity Market Share, 2023 VS 2030
9.6 China
9.6.1 China Veterinary Pain Medication Market Size, 2019-2030
9.6.2 By Type, China Veterinary Pain Medication Sales Quantity Market Share, 2023 VS 2030
9.6.3 By Application, China Veterinary Pain Medication Sales Quantity Market Share, 2023 VS 2030
9.7 Japan
9.7.1 Japan Veterinary Pain Medication Market Size, 2019-2030
9.7.2 By Type, Japan Veterinary Pain Medication Sales Quantity Market Share, 2023 VS 2030
9.7.3 By Application, Japan Veterinary Pain Medication Sales Quantity Market Share, 2023 VS 2030
9.8 South Korea
9.8.1 South Korea Veterinary Pain Medication Market Size, 2019-2030
9.8.2 By Type, South Korea Veterinary Pain Medication Sales Quantity Market Share, 2023 VS 2030
9.8.3 By Application, South Korea Veterinary Pain Medication Sales Quantity Market Share, 2023 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Veterinary Pain Medication Market Size, 2019-2030
9.9.2 By Type, Southeast Asia Veterinary Pain Medication Sales Quantity Market Share, 2023 VS 2030
9.9.3 By Application, Southeast Asia Veterinary Pain Medication Sales Quantity Market Share, 2023 VS 2030
9.10 India
9.10.1 India Veterinary Pain Medication Market Size, 2019-2030
9.10.2 By Type, India Veterinary Pain Medication Sales Quantity Market Share, 2023 VS 2030
9.10.3 By Application, India Veterinary Pain Medication Sales Quantity Market Share, 2023 VS 2030
9.11 Middle East & Africa
9.11.1 Middle East & Africa Veterinary Pain Medication Market Size, 2019-2030
9.11.2 By Type, Middle East & Africa Veterinary Pain Medication Sales Quantity Market Share, 2023 VS 2030
9.11.3 By Application, Middle East & Africa Veterinary Pain Medication Sales Quantity Market Share, 2023 VS 2030
10 Manufacturers Profile
10.1 Boehringer Ingelheim
10.1.1 Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
10.1.2 Boehringer Ingelheim Veterinary Pain Medication Models, Specifications, and Application
10.1.3 Boehringer Ingelheim Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Boehringer Ingelheim Company Profile and Main Business
10.1.5 Boehringer Ingelheim Recent Developments
10.2 Elanco
10.2.1 Elanco Company Information, Head Office, Market Area, and Industry Position
10.2.2 Elanco Veterinary Pain Medication Models, Specifications, and Application
10.2.3 Elanco Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Elanco Company Profile and Main Business
10.2.5 Elanco Recent Developments
10.3 Zoetis
10.3.1 Zoetis Company Information, Head Office, Market Area, and Industry Position
10.3.2 Zoetis Veterinary Pain Medication Models, Specifications, and Application
10.3.3 Zoetis Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Zoetis Company Profile and Main Business
10.3.5 Zoetis Recent Developments
10.4 Baxter
10.4.1 Baxter Company Information, Head Office, Market Area, and Industry Position
10.4.2 Baxter Veterinary Pain Medication Models, Specifications, and Application
10.4.3 Baxter Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Baxter Company Profile and Main Business
10.4.5 Baxter Recent Developments
10.5 Halyard
10.5.1 Halyard Company Information, Head Office, Market Area, and Industry Position
10.5.2 Halyard Veterinary Pain Medication Models, Specifications, and Application
10.5.3 Halyard Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Halyard Company Profile and Main Business
10.5.5 Halyard Recent Developments
10.6 Endo International
10.6.1 Endo International Company Information, Head Office, Market Area, and Industry Position
10.6.2 Endo International Veterinary Pain Medication Models, Specifications, and Application
10.6.3 Endo International Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Endo International Company Profile and Main Business
10.6.5 Endo International Recent Developments
10.7 Forest Laboratories
10.7.1 Forest Laboratories Company Information, Head Office, Market Area, and Industry Position
10.7.2 Forest Laboratories Veterinary Pain Medication Models, Specifications, and Application
10.7.3 Forest Laboratories Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Forest Laboratories Company Profile and Main Business
10.7.5 Forest Laboratories Recent Developments
10.8 Medtronic
10.8.1 Medtronic Company Information, Head Office, Market Area, and Industry Position
10.8.2 Medtronic Veterinary Pain Medication Models, Specifications, and Application
10.8.3 Medtronic Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Medtronic Company Profile and Main Business
10.8.5 Medtronic Recent Developments
10.9 Bayer Pharma AG
10.9.1 Bayer Pharma AG Company Information, Head Office, Market Area, and Industry Position
10.9.2 Bayer Pharma AG Veterinary Pain Medication Models, Specifications, and Application
10.9.3 Bayer Pharma AG Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Bayer Pharma AG Company Profile and Main Business
10.9.5 Bayer Pharma AG Recent Developments
10.10 Ceva Sante Animale
10.10.1 Ceva Sante Animale Company Information, Head Office, Market Area, and Industry Position
10.10.2 Ceva Sante Animale Veterinary Pain Medication Models, Specifications, and Application
10.10.3 Ceva Sante Animale Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Ceva Sante Animale Company Profile and Main Business
10.10.5 Ceva Sante Animale Recent Developments
10.11 Ringpu Bio-technology
10.11.1 Ringpu Bio-technology Company Information, Head Office, Market Area, and Industry Position
10.11.2 Ringpu Bio-technology Veterinary Pain Medication Models, Specifications, and Application
10.11.3 Ringpu Bio-technology Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Ringpu Bio-technology Company Profile and Main Business
10.11.5 Ringpu Bio-technology Recent Developments
10.12 Ruicheng Lvman Biological Pharmaceutical Co., Ltd.
10.12.1 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
10.12.2 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Models, Specifications, and Application
10.12.3 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.12.4 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Company Profile and Main Business
10.12.5 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Recent Developments
10.13 Norbrook Laboratories
10.13.1 Norbrook Laboratories Company Information, Head Office, Market Area, and Industry Position
10.13.2 Norbrook Laboratories Veterinary Pain Medication Models, Specifications, and Application
10.13.3 Norbrook Laboratories Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.13.4 Norbrook Laboratories Company Profile and Main Business
10.13.5 Norbrook Laboratories Recent Developments
10.14 Merck & Co
10.14.1 Merck & Co Company Information, Head Office, Market Area, and Industry Position
10.14.2 Merck & Co Veterinary Pain Medication Models, Specifications, and Application
10.14.3 Merck & Co Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.14.4 Merck & Co Company Profile and Main Business
10.14.5 Merck & Co Recent Developments
10.15 Bostonscientific
10.15.1 Bostonscientific Company Information, Head Office, Market Area, and Industry Position
10.15.2 Bostonscientific Veterinary Pain Medication Models, Specifications, and Application
10.15.3 Bostonscientific Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.15.4 Bostonscientific Company Profile and Main Business
10.15.5 Bostonscientific Recent Developments
10.16 Lilly
10.16.1 Lilly Company Information, Head Office, Market Area, and Industry Position
10.16.2 Lilly Veterinary Pain Medication Models, Specifications, and Application
10.16.3 Lilly Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.16.4 Lilly Company Profile and Main Business
10.16.5 Lilly Recent Developments
10.17 Pfizer
10.17.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.17.2 Pfizer Veterinary Pain Medication Models, Specifications, and Application
10.17.3 Pfizer Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.17.4 Pfizer Company Profile and Main Business
10.17.5 Pfizer Recent Developments
10.18 Harbin Bolai Pharmaceutical Co., Ltd.
10.18.1 Harbin Bolai Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
10.18.2 Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Models, Specifications, and Application
10.18.3 Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.18.4 Harbin Bolai Pharmaceutical Co., Ltd. Company Profile and Main Business
10.18.5 Harbin Bolai Pharmaceutical Co., Ltd. Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Veterinary Pain Medication Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Veterinary Pain Medication Market Restraints
Table 3. Veterinary Pain Medication Market Trends
Table 4. Veterinary Pain Medication Industry Policy
Table 5. Global Veterinary Pain Medication Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Veterinary Pain Medication Revenue Share by Company, 2019-2024, Ranked by Data of 2022
Table 7. Global Veterinary Pain Medication Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Veterinary Pain Medication Sales Quantity by Company, 2019-2024, Ranked by Data of 2022
Table 9. Global Veterinary Pain Medication Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)
Table 10. Global Veterinary Pain Medication Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Veterinary Pain Medication Mergers & Acquisitions, Expansion Plans
Table 12. Global Veterinary Pain Medication Manufacturers Product Type
Table 13. Head Office and Veterinary Pain Medication Production Site of Key Manufacturer
Table 14. Veterinary Pain Medication Capacity of Major Manufacturers and Future Plan
Table 15. China Veterinary Pain Medication Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022
Table 16. China Veterinary Pain Medication Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022
Table 17. China Veterinary Pain Medication Sales Quantity by Company, 2019-2024, Ranked by Data of 2022
Table 18. Global Veterinary Pain Medication Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 19. Global Veterinary Pain Medication Production by Region, 2019-2024, (K Units)
Table 20. Global Veterinary Pain Medication Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Veterinary Pain Medication Upstream (Raw Materials)
Table 22. Global Veterinary Pain Medication Typical Customers
Table 23. Veterinary Pain Medication Typical Distributors
Table 24. By Type, Global Veterinary Pain Medication Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 25. By Application, Global Veterinary Pain Medication Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 26. By Region, Global Veterinary Pain Medication Consumption Value, 2019 VS 2024 VS 2030, US$ Million
Table 27. By Region, Global Veterinary Pain Medication Consumption Value, 2019-2030, US$ Million
Table 28. By Region, Global Veterinary Pain Medication Sales Quantity, 2019-2030, (K Units)
Table 29. By Country, Global Veterinary Pain Medication Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Country, Global Veterinary Pain Medication Consumption Value, 2019-2030, US$ Million
Table 31. By Country, Global Veterinary Pain Medication Consumption Value Market Share, 2019-2030
Table 32. By Country, Global Veterinary Pain Medication Sales Quantity, 2019-2030, (K Units)
Table 33. By Country, Global Veterinary Pain Medication Sales Quantity Market Share, 2019-2030
Table 34. Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
Table 35. Boehringer Ingelheim Veterinary Pain Medication Models, Specifications, and Application
Table 36. Boehringer Ingelheim Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 37. Boehringer Ingelheim Company Profile and Main Business
Table 38. Boehringer Ingelheim Recent Developments
Table 39. Elanco Company Information, Head Office, Market Area, and Industry Position
Table 40. Elanco Veterinary Pain Medication Models, Specifications, and Application
Table 41. Elanco Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Elanco Company Profile and Main Business
Table 43. Elanco Recent Developments
Table 44. Zoetis Company Information, Head Office, Market Area, and Industry Position
Table 45. Zoetis Veterinary Pain Medication Models, Specifications, and Application
Table 46. Zoetis Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Zoetis Company Profile and Main Business
Table 48. Zoetis Recent Developments
Table 49. Baxter Company Information, Head Office, Market Area, and Industry Position
Table 50. Baxter Veterinary Pain Medication Models, Specifications, and Application
Table 51. Baxter Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Baxter Company Profile and Main Business
Table 53. Baxter Recent Developments
Table 54. Halyard Company Information, Head Office, Market Area, and Industry Position
Table 55. Halyard Veterinary Pain Medication Models, Specifications, and Application
Table 56. Halyard Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Halyard Company Profile and Main Business
Table 58. Halyard Recent Developments
Table 59. Endo International Company Information, Head Office, Market Area, and Industry Position
Table 60. Endo International Veterinary Pain Medication Models, Specifications, and Application
Table 61. Endo International Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Endo International Company Profile and Main Business
Table 63. Endo International Recent Developments
Table 64. Forest Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 65. Forest Laboratories Veterinary Pain Medication Models, Specifications, and Application
Table 66. Forest Laboratories Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Forest Laboratories Company Profile and Main Business
Table 68. Forest Laboratories Recent Developments
Table 69. Medtronic Company Information, Head Office, Market Area, and Industry Position
Table 70. Medtronic Veterinary Pain Medication Models, Specifications, and Application
Table 71. Medtronic Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Medtronic Company Profile and Main Business
Table 73. Medtronic Recent Developments
Table 74. Bayer Pharma AG Company Information, Head Office, Market Area, and Industry Position
Table 75. Bayer Pharma AG Veterinary Pain Medication Models, Specifications, and Application
Table 76. Bayer Pharma AG Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. Bayer Pharma AG Company Profile and Main Business
Table 78. Bayer Pharma AG Recent Developments
Table 79. Ceva Sante Animale Company Information, Head Office, Market Area, and Industry Position
Table 80. Ceva Sante Animale Veterinary Pain Medication Models, Specifications, and Application
Table 81. Ceva Sante Animale Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. Ceva Sante Animale Company Profile and Main Business
Table 83. Ceva Sante Animale Recent Developments
Table 84. Ringpu Bio-technology Company Information, Head Office, Market Area, and Industry Position
Table 85. Ringpu Bio-technology Veterinary Pain Medication Models, Specifications, and Application
Table 86. Ringpu Bio-technology Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. Ringpu Bio-technology Company Profile and Main Business
Table 88. Ringpu Bio-technology Recent Developments
Table 89. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 90. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Models, Specifications, and Application
Table 91. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Company Profile and Main Business
Table 93. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Recent Developments
Table 94. Norbrook Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 95. Norbrook Laboratories Veterinary Pain Medication Models, Specifications, and Application
Table 96. Norbrook Laboratories Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 97. Norbrook Laboratories Company Profile and Main Business
Table 98. Norbrook Laboratories Recent Developments
Table 99. Merck & Co Company Information, Head Office, Market Area, and Industry Position
Table 100. Merck & Co Veterinary Pain Medication Models, Specifications, and Application
Table 101. Merck & Co Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 102. Merck & Co Company Profile and Main Business
Table 103. Merck & Co Recent Developments
Table 104. Bostonscientific Company Information, Head Office, Market Area, and Industry Position
Table 105. Bostonscientific Veterinary Pain Medication Models, Specifications, and Application
Table 106. Bostonscientific Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 107. Bostonscientific Company Profile and Main Business
Table 108. Bostonscientific Recent Developments
Table 109. Lilly Company Information, Head Office, Market Area, and Industry Position
Table 110. Lilly Veterinary Pain Medication Models, Specifications, and Application
Table 111. Lilly Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 112. Lilly Company Profile and Main Business
Table 113. Lilly Recent Developments
Table 114. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 115. Pfizer Veterinary Pain Medication Models, Specifications, and Application
Table 116. Pfizer Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 117. Pfizer Company Profile and Main Business
Table 118. Pfizer Recent Developments
Table 119. Harbin Bolai Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 120. Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Models, Specifications, and Application
Table 121. Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 122. Harbin Bolai Pharmaceutical Co., Ltd. Company Profile and Main Business
Table 123. Harbin Bolai Pharmaceutical Co., Ltd. Recent Developments
List of Figures
Figure 1. Veterinary Pain Medication Picture
Figure 2. Global Veterinary Pain Medication Consumption Value, (US$ million) & (2019-2030)
Figure 3. Global Veterinary Pain Medication Sales Quantity, (K Units) & (2019-2030)
Figure 4. Global Veterinary Pain Medication Average Selling Price (ASP), (2019-2030) & (US$/Unit)
Figure 5. China Veterinary Pain Medication Consumption Value, (US$ million) & (2019-2030)
Figure 6. China Veterinary Pain Medication Sales Quantity (K Units) & (2019-2030)
Figure 7. China Veterinary Pain Medication Average Selling Price (ASP), (US$/Unit) & (2019-2030)
Figure 8. By Consumption Value, China Veterinary Pain Medication Market Share of Global, 2019-2030
Figure 9. By Sales Quantity, China Veterinary Pain Medication Market Share of Global, 2019-2030
Figure 10. Global Veterinary Pain Medication Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Veterinary Pain Medication Key Participants, Market Share, 2022
Figure 12. Global Veterinary Pain Medication Capacity, Production and Capacity Utilization, 2019-2030
Figure 13. Global Veterinary Pain Medication Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Veterinary Pain Medication Production Market Share & Forecast by Region, 2019-2030
Figure 15. Veterinary Pain Medication Industry Chain
Figure 16. Veterinary Pain Medication Procurement Model
Figure 17. Veterinary Pain Medication Sales Model
Figure 18. Veterinary Pain Medication Sales Channels, Direct Sales, and Distribution
Figure 19. Injection Medicines
Figure 20. Oral Medicines
Figure 21. By Type, Global Veterinary Pain Medication Consumption Value, 2019-2030, US$ Million
Figure 22. By Type, Global Veterinary Pain Medication Consumption Value Market Share, 2019-2030
Figure 23. By Type, Global Veterinary Pain Medication Sales Quantity, 2019-2030, (K Units)
Figure 24. By Type, Global Veterinary Pain Medication Sales Quantity Market Share, 2019-2030
Figure 25. By Type, Global Veterinary Pain Medication Average Selling Price (ASP), 2019-2030, (US$/Unit)
Figure 26. Veterinary Hospitals
Figure 27. Veterinary Clinics
Figure 28. Others
Figure 29. By Application, Global Veterinary Pain Medication Consumption Value, 2019-2030, US$ Million
Figure 30. By Application, Global Veterinary Pain Medication Consumption Value Market Share, 2019-2030
Figure 31. By Application, Global Veterinary Pain Medication Sales Quantity, 2019-2030, (K Units)
Figure 32. By Application, Global Veterinary Pain Medication Sales Quantity Market Share, 2019-2030
Figure 33. By Application, Global Veterinary Pain Medication Average Selling Price (ASP), 2019-2030, (US$/Unit)
Figure 34. By Region, Global Veterinary Pain Medication Consumption Value Market Share, 2019-2030
Figure 35. By Region, Global Veterinary Pain Medication Sales Quantity Market Share, 2019-2030
Figure 36. North America Veterinary Pain Medication Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 37. By Country, North America Veterinary Pain Medication Consumption Value Market Share, 2022
Figure 38. Europe Veterinary Pain Medication Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 39. By Country, Europe Veterinary Pain Medication Consumption Value Market Share, 2022
Figure 40. Asia Pacific Veterinary Pain Medication Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 41. By Country/Region, Asia Pacific Veterinary Pain Medication Consumption Value Market Share, 2022
Figure 42. South America Veterinary Pain Medication Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 43. By Country, South America Veterinary Pain Medication Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Veterinary Pain Medication Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 45. U.S. Veterinary Pain Medication Sales Quantity, 2019-2030, (K Units)
Figure 46. By Type, U.S. Veterinary Pain Medication Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Veterinary Pain Medication Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Veterinary Pain Medication Sales Quantity, 2019-2030, (K Units)
Figure 49. By Type, Europe Veterinary Pain Medication Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Veterinary Pain Medication Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Veterinary Pain Medication Sales Quantity, 2019-2030, (K Units)
Figure 52. By Type, China Veterinary Pain Medication Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Veterinary Pain Medication Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Veterinary Pain Medication Sales Quantity, 2019-2030, (K Units)
Figure 55. By Type, Japan Veterinary Pain Medication Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Veterinary Pain Medication Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Veterinary Pain Medication Sales Quantity, 2019-2030, (K Units)
Figure 58. By Type, South Korea Veterinary Pain Medication Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Veterinary Pain Medication Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Veterinary Pain Medication Sales Quantity, 2019-2030, (K Units)
Figure 61. By Type, Southeast Asia Veterinary Pain Medication Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Veterinary Pain Medication Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Veterinary Pain Medication Sales Quantity, 2019-2030, (K Units)
Figure 64. By Type, India Veterinary Pain Medication Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Veterinary Pain Medication Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Veterinary Pain Medication Sales Quantity, 2019-2030, (K Units)
Figure 67. By Type, Middle East & Africa Veterinary Pain Medication Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Veterinary Pain Medication Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|